Medication Profile · Updated March 2026
Ozempic (Semaglutide): Cost, Dosing, and Where to Get It in 2026
Ozempic is the GLP-1 that started the cultural conversation around weight loss medication. I am personally on Mounjaro (tirzepatide), but half the people who message me about GLP-1s are asking about Ozempic. It has the longest track record, the most real-world data, and a pricing picture that has shifted dramatically over the past year. This is what you need to know before starting it in 2026.
Quick Facts
| Detail | Ozempic |
|---|---|
| Generic Name | Semaglutide |
| Brand Name | Ozempic |
| Manufacturer | Novo Nordisk |
| FDA Approval | December 2017 (type 2 diabetes) |
| Drug Class | GLP-1 receptor agonist |
| Administration | Weekly subcutaneous injection (pre-filled pen) |
| Available Doses | 0.25 mg, 0.5 mg, 1 mg, 2 mg |
| Brand Price (no insurance) | ~$892/month |
| Compounded Semaglutide | $149 to $299/month |
| With Insurance Copay | $25 to $100/month (varies by plan) |
| Weight Loss (trials) | ~15% body weight at 68 weeks (STEP 8) |
How Ozempic Works
Ozempic is a GLP-1 receptor agonist. It mimics a hormone your body naturally produces called glucagon-like peptide-1 (GLP-1). When you inject semaglutide, it activates GLP-1 receptors in the brain and gut, producing three main effects:
- Appetite reduction. GLP-1 signals satiety to the hypothalamus in your brain. You feel full sooner and think about food less. This is the primary driver of weight loss.
- Slower gastric emptying. Food stays in your stomach longer, which keeps you feeling satisfied between meals and reduces blood sugar spikes after eating.
- Improved insulin response. Your pancreas releases insulin more effectively in response to food. This is why Ozempic was originally approved for type 2 diabetes.
The weight loss from Ozempic is dose-dependent. Higher doses produce more appetite suppression and more weight loss, which is why the dosing schedule starts low and gradually increases over several months.
For a deeper breakdown of the single-action GLP-1 mechanism vs. dual-action drugs like Mounjaro, see our Mounjaro vs Ozempic comparison.
Dosing Schedule
Ozempic uses a step-up dosing protocol to minimize side effects. You start at the lowest dose and increase every four weeks until you reach a therapeutic level.
| Week | Dose | Purpose |
|---|---|---|
| Weeks 1 to 4 | 0.25 mg | Initiation dose. Lets your body adjust. Minimal weight loss expected. |
| Weeks 5 to 8 | 0.5 mg | First therapeutic dose. Appetite suppression starts becoming noticeable. |
| Weeks 9 to 12 | 1 mg | Standard maintenance dose for most patients. Many stay here. |
| Week 13+ | 2 mg | Maximum dose. Used if 1 mg is insufficient for blood sugar or weight goals. |
Most providers keep patients at 1 mg unless there is a clear clinical reason to increase. The jump from 1 mg to 2 mg often brings more side effects without a proportional increase in benefit for everyone. Your prescriber should base this decision on your blood sugar response and weight trajectory.
One important note: Ozempic’s maximum dose (2 mg) is lower than Wegovy’s (2.4 mg). Wegovy was specifically designed for weight management and includes the 1.7 mg and 2.4 mg dose levels that Ozempic does not have. If weight loss is your primary goal and you have plateaued at 2 mg Ozempic, your doctor may consider switching you to Wegovy for the higher dosing option.
Weight Loss Results
Ozempic was originally approved for type 2 diabetes, not weight management. But the clinical trial data shows meaningful weight loss across multiple studies.
STEP 8 Trial (semaglutide 2.4 mg vs. 1 mg):
- Participants on semaglutide 2.4 mg (the Wegovy dose) lost approximately 15.8% of body weight at 68 weeks
- Participants on semaglutide 1 mg (the standard Ozempic dose) lost approximately 12.2% of body weight at 68 weeks
SUSTAIN Trials (Ozempic-specific):
- SUSTAIN 1: 3.7 kg (8.2 lbs) weight loss at 30 weeks with 0.5 mg
- SUSTAIN 2: 4.3 to 6.1 kg (9.5 to 13.4 lbs) weight loss at 56 weeks
What does this mean in real terms? For a 220 lb person on the standard 1 mg Ozempic dose, you can expect to lose roughly 25 to 30 lbs over a year. At the 2 mg dose or if switched to Wegovy’s 2.4 mg, the number is closer to 30 to 35 lbs.
These are averages. Individual results vary significantly based on diet, exercise, starting weight, and how your body responds to the medication. From my own experience tracking DEXA scans while on a GLP-1, the composition of that weight loss matters as much as the number on the scale. If you are not doing resistance training, a meaningful portion of the weight you lose will be muscle. Our fat loss vs weight loss guide breaks this down in detail.
For context on how Ozempic compares to Mounjaro’s clinical trial results (roughly 22.5% body weight loss at the highest dose), see the full comparison.
What Ozempic Costs in 2026
The cost picture for Ozempic has gotten more nuanced over the past year. Here is what you are actually looking at.
Brand-Name Ozempic
The list price for brand-name Ozempic is approximately $892 per month without insurance. This is the price you would pay at a retail pharmacy with no coverage. In practice, very few people pay this full amount because of savings programs and insurance.
Novo Nordisk Savings Card: If you have commercial insurance (not Medicare or Medicaid), Novo Nordisk offers a savings card that can bring your copay down to as low as $25 per month. This card does not work for everyone and has annual limits. Check NovoCare.com for current eligibility.
With insurance: Most commercial insurance plans cover Ozempic for type 2 diabetes. Typical copays range from $25 to $100 per month depending on your plan’s formulary tier. Coverage for weight loss (off-label use) is less consistent. See our insurance coverage guide for strategies to get approved.
Compounded Semaglutide
Compounded semaglutide contains the same active ingredient as Ozempic but is produced by licensed compounding pharmacies rather than Novo Nordisk. It costs significantly less: $149 to $299 per month through most telehealth providers.
The key tradeoff: compounded semaglutide has not gone through FDA review as a finished product. The raw ingredient is FDA-approved, but the final compounded medication has not been evaluated for safety, efficacy, or manufacturing quality in the same way brand-name Ozempic has. For a detailed breakdown of the differences, read our compounded vs brand-name guide.
Cost Comparison Summary
| Option | Monthly Cost | Notes |
|---|---|---|
| Brand-name (no insurance) | ~$892 | Full list price at retail pharmacy |
| Brand-name (with savings card) | $25 to $100 | Commercial insurance required. Annual limits apply. |
| Brand-name (with insurance) | $25 to $100 | Varies by plan. Diabetes indication covered more consistently. |
| Compounded semaglutide | $149 to $299 | No insurance needed. Through telehealth providers. |
For a full pricing breakdown across all providers and medication types, see our cheapest GLP-1 online guide.
Compare semaglutide prices from verified providers
See Provider Comparison →Where to Get Ozempic (or Compounded Semaglutide) Online
These are the top-rated telehealth providers offering compounded semaglutide, ranked by our ClearScore methodology. Brand-name Ozempic typically requires a prescription from your primary care doctor or endocrinologist, though some of these providers also prescribe brand-name if you have insurance.
| Provider | ClearScore | Monthly Price | Key Details |
|---|---|---|---|
| MEDVi | 83 | $199/mo | Doctor-led. Includes labs and ongoing clinical oversight. |
| Ro | 82 | $149/mo | Lowest starting price among major platforms. Membership fee on top. |
| Red Mountain | 81 | $299/mo | In-person and telehealth. Established weight loss clinic network. |
| Hims | 80 | $199/mo | Large platform. Polished app. Regulatory risk from Novo Nordisk lawsuit. |
| Hers | 79 | $199/mo | Same company as Hims, branded for women. Same medication and pricing. |
For a full comparison of every GLP-1 telehealth provider we track (with pricing, insurance acceptance, and coverage maps), visit our provider directory.
Common Side Effects
GLP-1 medications share a similar side effect profile. Most side effects are gastrointestinal and tend to be worst during the first few weeks of each dose increase. They typically improve as your body adjusts.
Most common (affecting 10% or more of patients in trials):
- Nausea (the most frequently reported, especially in the first 4 to 8 weeks)
- Diarrhea
- Vomiting
- Constipation
- Abdominal pain
Less common but reported:
- Headache
- Fatigue
- Dizziness
- Injection site reactions (redness, swelling)
- Decreased appetite (this is technically the mechanism working, not a side effect)
Serious but rare:
- Pancreatitis (inflammation of the pancreas). Seek medical attention for severe, persistent abdominal pain.
- Gallbladder problems, including gallstones
- Changes in vision in patients with type 2 diabetes (diabetic retinopathy)
- Kidney problems, usually related to dehydration from nausea/vomiting
Boxed warning: Semaglutide carries a boxed warning about thyroid C-cell tumors observed in rodent studies. This risk has not been confirmed in humans, but Ozempic is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
For a month-by-month breakdown of what to expect (and what actually helped me manage GI side effects on Mounjaro), read our GLP-1 side effects guide.
Ozempic vs. Related Medications
Ozempic exists in a family of GLP-1 drugs. Here is how it compares.
Ozempic vs. Wegovy: Same active ingredient (semaglutide), different approved uses. Wegovy goes up to 2.4 mg and is FDA-approved for weight management. Ozempic maxes out at 2 mg and is approved for diabetes. If weight loss is your goal, Wegovy is the version designed for you. Full Wegovy profile.
Ozempic vs. Mounjaro: Mounjaro (tirzepatide) works on two receptors (GIP and GLP-1) compared to Ozempic’s one (GLP-1 only). Clinical trials show roughly 22.5% body weight loss with Mounjaro vs. 15% with semaglutide. Full comparison.
Ozempic vs. Compounded Semaglutide: Same molecule, different source. Brand Ozempic is manufactured by Novo Nordisk and fully FDA-approved. Compounded semaglutide comes from 503A or 503B compounding pharmacies and costs a fraction of the price. Compounded vs brand-name guide.